Oral Presentations at the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and…
Source: Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease
Wednesday, April 1, 2015
Emmaus Life Sciences presents Phase 3 clinical trial of PGLG treatment for sickle cell disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment